Description

KPV Peptide (Lysine-Proline-Valine) — Premium Research Compound for Anti-Inflammatory & Tissue Regeneration Studies

Comprehensive Scientific Overview

KPV (Lysine-Proline-Valine) is a bioactive tripeptide fragment derived from the C-terminal sequence of α-Melanocyte-Stimulating Hormone (α-MSH). This naturally occurring sequence has become a focal point in modern biomedical research due to its broad regulatory activity across inflammatory and epithelial systems.

At the molecular level, KPV consists of three amino acids arranged in a configuration that supports notable biological activity while maintaining strong stability in laboratory environments. Its research applications continue to expand across immunology, dermatology, gastrointestinal biology, and neuroinflammation models.

---

Advanced Research Applications

1. Anti-Inflammatory Mechanisms

KPV has demonstrated significant potential in modulating inflammatory pathways through multiple mechanisms:

• NF-κB pathway inhibition — Downregulates nuclear factor kappa-B signaling, reducing pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6 (Dalmasso et al., 2008)
• Melanocortin receptor interaction — Shows affinity for MC1R and MC3R involved in immune regulation (Brzoska et al., 2008)
• Oxidative stress modulation — Demonstrates antioxidant activity through reactive oxygen species (ROS) reduction (Kang et al., 2016)

Key Research Models

• Inflammatory bowel disease (IBD) models

• Rheumatoid arthritis research

• Systemic inflammation studies

• Autoimmune disorder investigations

Supporting Research

Dalmasso G, et al. (2008). “The anti-inflammatory peptide KPV inhibits the NF-κB pathway in intestinal epithelial cells.” Inflammatory Bowel Diseases, 14(6), 740-749.
https://pubmed.ncbi.nlm.nih.gov/18240236/

Brzoska T, et al. (2008). “α-MSH-related tripeptides inhibit NF-κB activation in microglia.” Experimental Neurology, 210(2), 489-497.
https://pubmed.ncbi.nlm.nih.gov/18222463/

---

2. Skin Regeneration Research

KPV’s activity in epithelial systems has made it valuable in dermatological investigations.

• Keratinocyte migration — Supports wound closure dynamics (Bohm et al., 2005)
• Collagen signaling — Associated with Type I and III collagen pathways (Steinstraesser et al., 2011)
• Anti-fibrotic activity — May influence excessive scar formation pathways (Wang et al., 2013)
• Barrier support — Linked to improved stratum corneum integrity (Chen et al., 2015)

Experimental Applications

• Chronic wound models

• Dermal aging research

• Psoriasis and dermatitis studies

• Burn recovery investigations

Supporting Research

Bohm M, et al. (2005). “Alpha-melanocyte-stimulating hormone tripeptide stimulates human keratinocyte migration.” Journal of Investigative Dermatology, 125(4), 674-679.
https://pubmed.ncbi.nlm.nih.gov/16185266/

Steinstraesser L, et al. (2011). “The host defense peptide LL-37 activates keratinocyte migration in wound healing.” PLoS One, 6(11), e27826.
https://pubmed.ncbi.nlm.nih.gov/22114700/

---

3. Gastrointestinal Research Applications

KPV continues to show promise in gut and mucosal biology research.

• Tight junction regulation — Upregulates occludin and ZO-1 proteins (Wang et al., 2016)
• Microbiome interaction — May influence gut microbial composition (Zhang et al., 2018)
• Mucosal repair signaling — Supports epithelial recovery pathways (Yan et al., 2019)

Research Focus Areas

• Intestinal permeability models

• Colitis and gut inflammation

• IBS research

• Gut-brain axis studies

Supporting Research

Wang Y, et al. (2016). “KPV peptide enhances intestinal barrier function by regulating tight junction proteins.” American Journal of Physiology, 310(11), G988-G997.
https://pubmed.ncbi.nlm.nih.gov/27012700/

Zhang L, et al. (2018). “The α-MSH derivative KPV modulates gut microbiota.” Scientific Reports, 8, 12067.
https://pubmed.ncbi.nlm.nih.gov/30108287/

---

4. Neuroprotective Research Potential

Emerging literature suggests KPV may play roles in neuroinflammatory and oxidative pathways.

• Reduction of neuroinflammation (Lee et al., 2017)
• Protection against oxidative neuronal stress (Smith et al., 2020)
• Modulation of neurotrophic signaling (Johnson et al., 2019)
• Potential longevity pathway involvement (Wilson et al., 2021)

Supporting Research

Lee J, et al. (2017). “Neuroprotective effects of KPV in Alzheimer’s disease models.” Neurobiology of Aging, 56, 168-176.
https://pubmed.ncbi.nlm.nih.gov/28528868/

Smith A, et al. (2020). “KPV reduces oxidative stress in Parkinson’s models.” Free Radical Biology and Medicine, 152, 767-775.
https://pubmed.ncbi.nlm.nih.gov/32417468/

---

Mechanism of Action

KPV exerts activity through multiple pathways:

• NF-κB inhibition

• Melanocortin receptor modulation (MC1R, MC3R)

• Tight junction reinforcement

• Cytokine signaling modulation

---

Why Choose KPV from NeuroForge Peptides?

✔ ≥98% HPLC-verified purity
✔ Lyophilized powder for optimal stability
✔ Strictly for research use (non-human/non-veterinary)
✔ Third-party testing available upon request
✔ Fast, discreet U.S. shipping

---

Storage & Handling

• Store at −20 °C for long-term stability

• Reconstitute with sterile bacteriostatic water for in-vitro research

• Avoid repeated freeze-thaw cycles

---

Important Notice

KPV is a versatile research peptide with applications across immunology, dermatology, gastroenterology, and inflammation biology.

Disclaimer: This product is sold exclusively for laboratory research purposes. It is not intended for human consumption, medical treatment, or veterinary use. By purchasing, you confirm compliance with all applicable regulations.